SPDL1 and neoplasm: However, there was no significant difference in serum sPD-L1 level between NSCLC patients and healthy subjects, and there was no correlation between serum sPD-L1 level and other clinicopathological features except tumor size (> 2.5 cm) (P> 0.05).